Global Microbial Alternative Protein Market Research Report 2021

1 Microbial Alternative Protein Market Overview

• 1.1 Product Overview and Scope of Microbial Alternative Protein
• 1.2 Microbial Alternative Protein Segment by Type
  • 1.2.1 Global Microbial Alternative Protein Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Emerging Alternative Protein
  • 1.2.3 Adolescent Alternative Protein
  • 1.2.4 Matured Alternative Protein
• 1.3 Microbial Alternative Protein Segment by Application
  • 1.3.1 Microbial Alternative Protein Sales Comparison by Application: (2021-2027)
  • 1.3.2 Food
  • 1.3.3 Feed
  • 1.3.4 Others
• 1.4 Global Microbial Alternative Protein Market Size Estimates and Forecasts
  • 1.4.1 Global Microbial Alternative Protein Revenue 2016-2027
  • 1.4.2 Global Microbial Alternative Protein Sales 2016-2027
  • 1.4.3 Microbial Alternative Protein Market Size by Region: 2016 Versus 2021 Versus 2027

2 Microbial Alternative Protein Market Competition by Manufacturers

• 2.1 Global Microbial Alternative Protein Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Microbial Alternative Protein Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Microbial Alternative Protein Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Microbial Alternative Protein Manufacturing Sites, Area Served, Product Type
• 2.5 Microbial Alternative Protein Market Competitive Situation and Trends
  • 2.5.1 Microbial Alternative Protein Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Microbial Alternative Protein Players Market Share by Revenue
  • 2.5.3 Global Microbial Alternative Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Microbial Alternative Protein Retrospective Market Scenario by Region

• 3.1 Global Microbial Alternative Protein Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Microbial Alternative Protein Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Microbial Alternative Protein Market Facts & Figures by Country
  • 3.3.1 North America Microbial Alternative Protein Sales by Country
  • 3.3.2 North America Microbial Alternative Protein Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Microbial Alternative Protein Market Facts & Figures by Country
  • 3.4.1 Europe Microbial Alternative Protein Sales by Country
  • 3.4.2 Europe Microbial Alternative Protein Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Microbial Alternative Protein Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Microbial Alternative Protein Sales by Region
  • 3.5.2 Asia Pacific Microbial Alternative Protein Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Microbial Alternative Protein Market Facts & Figures by Country
  • 3.6.1 Latin America Microbial Alternative Protein Sales by Country
  • 3.6.2 Latin America Microbial Alternative Protein Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Microbial Alternative Protein Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Microbial Alternative Protein Sales by Country
  • 3.7.2 Middle East and Africa Microbial Alternative Protein Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Microbial Alternative Protein Historic Market Analysis by Type

• 4.1 Global Microbial Alternative Protein Sales Market Share by Type (2016-2021)
• 4.2 Global Microbial Alternative Protein Revenue Market Share by Type (2016-2021)
• 4.3 Global Microbial Alternative Protein Price by Type (2016-2021)

5 Global Microbial Alternative Protein Historic Market Analysis by Application

• 5.1 Global Microbial Alternative Protein Sales Market Share by Application (2016-2021)
• 5.2 Global Microbial Alternative Protein Revenue Market Share by Application (2016-2021)
• 5.3 Global Microbial Alternative Protein Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 AgriProtein (South Africa)
  • 6.1.1 AgriProtein (South Africa) Corporation Information
  • 6.1.2 AgriProtein (South Africa) Description and Business Overview
  • 6.1.3 AgriProtein (South Africa) Microbial Alternative Protein Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 AgriProtein (South Africa) Product Portfolio
  • 6.1.5 AgriProtein (South Africa) Recent Developments/Updates
• 6.2 Ynsect (France)
  • 6.2.1 Ynsect (France) Corporation Information
  • 6.2.2 Ynsect (France) Description and Business Overview
  • 6.2.3 Ynsect (France) Microbial Alternative Protein Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Ynsect (France) Product Portfolio
  • 6.2.5 Ynsect (France) Recent Developments/Updates
• 6.3 Enterra Feed Corporation (Canada)
  • 6.3.1 Enterra Feed Corporation (Canada) Corporation Information
  • 6.3.2 Enterra Feed Corporation (Canada) Description and Business Overview
  • 6.3.3 Enterra Feed Corporation (Canada) Microbial Alternative Protein Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Enterra Feed Corporation (Canada) Product Portfolio
  • 6.3.5 Enterra Feed Corporation (Canada) Recent Developments/Updates
• 6.4 Protix (The Netherlands)
  • 6.4.1 Protix (The Netherlands) Corporation Information
  • 6.4.2 Protix (The Netherlands) Description and Business Overview
  • 6.4.3 Protix (The Netherlands) Microbial Alternative Protein Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Protix (The Netherlands) Product Portfolio
  • 6.4.5 Protix (The Netherlands) Recent Developments/Updates
• 6.5 Proti-Farm Holding NV (The Netherlands)
  • 6.5.1 Proti-Farm Holding NV (The Netherlands) Corporation Information
  • 6.5.2 Proti-Farm Holding NV (The Netherlands) Description and Business Overview
  • 6.5.3 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Proti-Farm Holding NV (The Netherlands) Product Portfolio
  • 6.5.5 Proti-Farm Holding NV (The Netherlands) Recent Developments/Updates
• 6.6 Entomo Farms (Canada)
  • 6.6.1 Entomo Farms (Canada) Corporation Information
  • 6.6.2 Entomo Farms (Canada) Description and Business Overview
  • 6.6.3 Entomo Farms (Canada) Microbial Alternative Protein Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Entomo Farms (Canada) Product Portfolio
  • 6.6.5 Entomo Farms (Canada) Recent Developments/Updates
• 6.7 Global Bugs Asia Co., Ltd. (Thailand)
  • 6.6.1 Global Bugs Asia Co., Ltd. (Thailand) Corporation Information
  • 6.6.2 Global Bugs Asia Co., Ltd. (Thailand) Description and Business Overview
  • 6.6.3 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Global Bugs Asia Co., Ltd. (Thailand) Product Portfolio
  • 6.7.5 Global Bugs Asia Co., Ltd. (Thailand) Recent Developments/Updates
• 6.8 Aspire Food Group (U.S.)
  • 6.8.1 Aspire Food Group (U.S.) Corporation Information
  • 6.8.2 Aspire Food Group (U.S.) Description and Business Overview
  • 6.8.3 Aspire Food Group (U.S.) Microbial Alternative Protein Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Aspire Food Group (U.S.) Product Portfolio
  • 6.8.5 Aspire Food Group (U.S.) Recent Developments/Updates
• 6.9 Tiny Farms (U.S.)
  • 6.9.1 Tiny Farms (U.S.) Corporation Information
  • 6.9.2 Tiny Farms (U.S.) Description and Business Overview
  • 6.9.3 Tiny Farms (U.S.) Microbial Alternative Protein Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Tiny Farms (U.S.) Product Portfolio
  • 6.9.5 Tiny Farms (U.S.) Recent Developments/Updates

7 Microbial Alternative Protein Manufacturing Cost Analysis

• 7.1 Microbial Alternative Protein Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Microbial Alternative Protein
• 7.4 Microbial Alternative Protein Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Microbial Alternative Protein Distributors List
• 8.3 Microbial Alternative Protein Customers

9 Microbial Alternative Protein Market Dynamics

• 9.1 Microbial Alternative Protein Industry Trends
• 9.2 Microbial Alternative Protein Growth Drivers
• 9.3 Microbial Alternative Protein Market Challenges
• 9.4 Microbial Alternative Protein Market Restraints

10 Global Market Forecast

• 10.1 Microbial Alternative Protein Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Microbial Alternative Protein by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Microbial Alternative Protein by Type (2022-2027)
• 10.2 Microbial Alternative Protein Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Microbial Alternative Protein by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Microbial Alternative Protein by Application (2022-2027)
• 10.3 Microbial Alternative Protein Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Microbial Alternative Protein by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Microbial Alternative Protein by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List